Evotec SE
EVONASDAQHealthcare● Active
$2.85
+$0.05(+1.79%)
Market Cap$1.0B
P/E Ratio—
52W High$4.44
52W Low$2.31
Evotec SE (EVO) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
EVO · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 6, 2026EPS Actual
-$0.48
Est. -$0.15 · -217.9%
Revenue
$0.22B
Est. $0.21B · +5.0%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 6, 2026
After Market Close
▼ Miss EPS▲ Beat Revenue
EVO reports quarterly as a NASDAQ-listed Drug Manufacturers - Specialty & Generic company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.36
Rev. $5.58B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.36
Rev. Est.$5.58B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 13, 2026 | $0.01 | — | — | — | $0.23B | — |
| ▼ Q2 FY2026 | May 6, 2026 | -$0.15 | -$0.48 | -217.9% | $0.22B | $0.21B | +5.0% |
| ▼ Q2 FY2026 | Apr 8, 2026 | $0.21 | $0.05 | -74.0% | $0.35B | $0.33B | +5.7% |
| ▼ Q4 FY2025 | Nov 5, 2025 | -$0.14 | -$0.14 | -1.4% | $0.19B | $0.24B | -20.0% |
| ▲ Q3 FY2025 | Aug 13, 2025 | -$0.18 | -$0.14 | +19.9% | $0.20B | $0.19B | +5.1% |
| ▼ Q2 FY2025 | May 6, 2025 | -$0.11 | -$0.19 | -77.3% | $0.22B | $0.28B | -20.5% |
| ▼ Q2 FY2025 | Apr 17, 2025 | $0.02 | -$0.12 | -768.1% | $0.23B | $0.21B | +11.6% |
| ▼ Q4 FY2024 | Nov 6, 2024 | -$0.08 | -$0.12 | -50.0% | $0.20B | $0.22B | -8.3% |
Q3 FY2026
Aug 13, 2026
EPS Actual
—
EPS Est.
$0.01
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 6, 2026Miss
EPS Actual
-$0.48
EPS Est.
-$0.15
EPS Surpr.
-217.9%
Revenue
$0.22B
Q2 FY2026
Apr 8, 2026Miss
EPS Actual
$0.05
EPS Est.
$0.21
EPS Surpr.
-74.0%
Revenue
$0.35B
Q4 FY2025
Nov 5, 2025Miss
EPS Actual
-$0.14
EPS Est.
-$0.14
EPS Surpr.
-1.4%
Revenue
$0.19B
Q3 FY2025
Aug 13, 2025Beat
EPS Actual
-$0.14
EPS Est.
-$0.18
EPS Surpr.
+19.9%
Revenue
$0.20B
Q2 FY2025
May 6, 2025Miss
EPS Actual
-$0.19
EPS Est.
-$0.11
EPS Surpr.
-77.3%
Revenue
$0.22B
Q2 FY2025
Apr 17, 2025Miss
EPS Actual
-$0.12
EPS Est.
$0.02
EPS Surpr.
-768.1%
Revenue
$0.23B
Q4 FY2024
Nov 6, 2024Miss
EPS Actual
-$0.12
EPS Est.
-$0.08
EPS Surpr.
-50.0%
Revenue
$0.20B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.06 | $0.06 | $0.06 | 1 |
| Q3 FY2027 | $0.04 | $0.05 | $0.05 | 1 |
| Q2 FY2027 | $0.03 | $0.03 | $0.03 | 1 |
| Q1 FY2027 | $0.02 | $0.02 | $0.02 | 1 |
| Q4 FY2026 | $-0.01 | $-0.01 | $-0.01 | 1 |
| Q3 FY2026 | $-0.08 | $-0.05 | $-0.02 | 2 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.2B | $0.2B | $0.2B | 1 |
| Q3 FY2027 | $0.2B | $0.2B | $0.2B | 1 |
| Q2 FY2027 | $0.2B | $0.2B | $0.2B | 1 |
| Q1 FY2027 | $0.2B | $0.2B | $0.2B | 1 |
| Q4 FY2026 | $0.2B | $0.2B | $0.2B | 1 |
| Q3 FY2026 | $0.2B | $0.2B | $0.2B | 2 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2026 | May 6, 2026 | -217.9% | $3.20 | $3.24 | +1.25% |
| ▼ Q2 FY2026 | Apr 8, 2026 | -74.0% | $2.58 | $2.69 | +4.26% |
| ▼ Q4 FY2025 | Nov 5, 2025 | -1.4% | $3.97 | $3.35 | -15.62% |
| ▲ Q3 FY2025 | Aug 13, 2025 | +19.9% | $3.81 | $3.81 | +0.00% |
| ▼ Q2 FY2025 | May 6, 2025 | -77.3% | $4.17 | $4.05 | -2.88% |
| ▼ Q2 FY2025 | Apr 17, 2025 | -768.1% | $3.27 | $3.60 | +10.09% |
| ▼ Q4 FY2024 | Nov 6, 2024 | -50.0% | $4.58 | $3.87 | -15.50% |
| ▼ Q3 FY2024 | Aug 14, 2024 | -222.2% | $3.32 | $3.31 | -0.30% |
Q2 FY2026+1.25%
Report Date
May 6, 2026
EPS Beat/Miss
-217.9%
Price Before
$3.20
Price After
$3.24
Q2 FY2026+4.26%
Report Date
Apr 8, 2026
EPS Beat/Miss
-74.0%
Price Before
$2.58
Price After
$2.69
Q4 FY2025-15.62%
Report Date
Nov 5, 2025
EPS Beat/Miss
-1.4%
Price Before
$3.97
Price After
$3.35
Q3 FY2025+0.00%
Report Date
Aug 13, 2025
EPS Beat/Miss
+19.9%
Price Before
$3.81
Price After
$3.81
Q2 FY2025-2.88%
Report Date
May 6, 2025
EPS Beat/Miss
-77.3%
Price Before
$4.17
Price After
$4.05
Q2 FY2025+10.09%
Report Date
Apr 17, 2025
EPS Beat/Miss
-768.1%
Price Before
$3.27
Price After
$3.60
Q4 FY2024-15.50%
Report Date
Nov 6, 2024
EPS Beat/Miss
-50.0%
Price Before
$4.58
Price After
$3.87
Q3 FY2024-0.30%
Report Date
Aug 14, 2024
EPS Beat/Miss
-222.2%
Price Before
$3.32
Price After
$3.31
Avg Beat Reaction+0.00%
Avg Miss Reaction-2.67%
Beat Rate1 / 8 quarters
Largest Move-15.62% (Q4 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: EVO ends December
Evotec SE (EVO) most recently reported earnings on May 6, 2026 for Q2 FY2026, posting EPS of $-0.48 — missing the analyst consensus of $-0.15 by -217.9%. The next EVO earnings date is expected around September 1, 2026.
Each quarter, investors track EVO earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. EVO revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
EVO's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
EVO earnings · 5 questionsEvotec SE's next earnings report is expected around September 1, 2026. EVO typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; EVO historically reports after market close (AMC).
EVO earnings datewhen is EVO earningsEVO next earnings datewhen does EVO report earningsEVO earnings calendar
▸ Source: FMP · Evotec SE SEC filings · US GAAP · Evotec SE SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026